AS
UTHR icon

Aware Super’s United Therapeutics UTHR Stock Holding History

Aware Super’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18.5M Sell
34,202
-38,328
-53% -$21.6M 0.26% 98
2026
Q1 		$43M Buy
+72,530
New +$36.1M 0.65% 28
2025
Q3 		$44.6M Hold
106,484
– – 0.61% 36
2025
Q2 		$30.6M Buy
106,484
+11,172
+12% +$3.34M 0.45% 62
2025
Q1 		$29.4M Buy
95,312
+8,632
+10% +$2.96M 0.5% 58
2024
Q4 		$30.6M Buy
+86,680
New +$31.9M 0.49% 61
2023
Q4 		$38.1M Buy
+78,146
New +$18M 0.51% 47

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Aware Super's UTHR Position: Q2 2026 in Review

Aware Super reduced its United Therapeutics (UTHR) stake by 53% in Q2 2026, selling an estimated $21.6M and leaving 34,202 shares worth $18.5M. The position accounts for 0.26% of the portfolio, ranked #98.

Aware Super first reported a position in UTHR in Q4 2023 and has held it in 7 quarters since. The position peaked at $44.6M in Q3 2025. 879 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Aware Super held 34,202 shares of United Therapeutics worth $18.5M as of Q2 2026.
  • Aware Super sold 38,328 United Therapeutics shares in Q2 2026, an estimated $21.6M.
  • United Therapeutics made up 0.26% of Aware Super's portfolio in Q2 2026, its #98 holding.
  • Aware Super first reported a position in United Therapeutics in Q4 2023 and has held it in 7 quarters since.
  • Aware Super's United Therapeutics position peaked at $44.6M in Q3 2025.
  • 879 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Aware Super's 13F filing for Q2 2026, filed 29 Jul 2026.